| Serial Number | 79324344 |
| Word Mark | HUB ORGANOIDS |
| Filing Date | Thursday, April 29, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 29, 2022 |
| Registration Number | 6909088 |
| Registration Date | Tuesday, November 29, 2022 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 13, 2022 |
| Description of Mark | The mark consists of a stylised representation of an organoid in blue outline to the left of the term "HUB" in blue and "ORGANOIDS" in black. The colour white represents background and/or transparent areas and is not claimed as a feature of the mark. |
| Certificate of Correction for Registration | In the statement, line 9," cell culture reagents for scientific and research use" should be deleted. |
| Goods and Services | Cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary research, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; chemicals for use in scientific medical research for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; chemicals for use in scientific medical research for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; culture media for medical and veterinary use, namely, for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations and substances for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx |
| Indication of Colors claimed | The color(s) blue and black is/are claimed as a feature of the mark. |
| Goods and Services | Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic and analytical preparations for use in science; chemicals used in science and industry; assays and assay preparations for scientific purposes; cell culture media for scientific research purposes |
| Goods and Services | Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services |
| NOT AVAILABLE | "ORGANOIDS" |
| Goods and Services | Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine testing services, namely, testing of pharmaceuticals; compound, drug and vaccine testing services; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 5, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 5, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 5, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, November 5, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | HUB Organoids IP B.V. |
| Party Type | 32 - New Owner After Registration |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | NL |
| Party Name | HUB Organoids B.V. IP |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | NL |
| Party Name | Stichting Hubrecht Organoid Technology |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 78 - NOT AVAILABLE |
| Address | NL |
| Event Date | Event Description |
| Thursday, October 28, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Thursday, November 4, 2021 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Friday, November 5, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 9, 2021 | APPLICATION FILING RECEIPT MAILED |
| Saturday, December 18, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, December 29, 2021 | ASSIGNED TO EXAMINER |
| Thursday, January 13, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, February 4, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, January 14, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, February 4, 2022 | REFUSAL PROCESSED BY MPU |
| Monday, February 28, 2022 | REFUSAL PROCESSED BY IB |
| Thursday, July 14, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, July 14, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 14, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 14, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, July 14, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 1, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, August 1, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 1, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 9, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 24, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, September 7, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, September 7, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, September 13, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 27, 2022 | NOTIFICATION PROCESSED BY IB |
| Tuesday, November 29, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 29, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Monday, December 19, 2022 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, February 28, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, March 23, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, March 23, 2023 | POST REGISTRATION ACTION MAILED - SEC. 7 |
| Thursday, March 23, 2023 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| Friday, March 31, 2023 | POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED |
| Friday, March 31, 2023 | CORRECTION UNDER SECTION 7 - PROCESSED |
| Monday, April 17, 2023 | FINAL DISPOSITION PROCESSED |
| Tuesday, May 9, 2023 | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED |
| Monday, April 17, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, May 9, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, January 4, 2024 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Sunday, December 17, 2023 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Friday, April 5, 2024 | CHANGE OF OWNER RECEIVED FROM IB |
| Tuesday, May 7, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |